5-YEAR EFFICACY AND SAFETY OF APREMILAST TREATMENT IN SUBJECTS WITH PSORIATIC ARTHRITIS: POOLED ANALYSIS OF THE PALACE STUDIES
Kavanaugh A, Gladman DD, Edwards CJ, Schett G, Guerette B, Delev N, Teng L, Paris M, Mease PJ (2018)
Publication Type: Conference contribution
Publication year: 2018
Journal
Book Volume: 77
Pages Range: 365-366
DOI: 10.1136/annrheumdis-2018-eular.3132
Authors with CRIS profile
Involved external institutions
University of California, San Diego
United States (USA) (US)
Celgene Corporation
United States (USA) (US)
Toronto Western Hospital
Canada (CA)
Swedish Medical Center
United States (USA) (US)
University of Southampton
United Kingdom (GB)
United States (USA) (US)
Celgene Corporation
United States (USA) (US)
Toronto Western Hospital
Canada (CA)
Swedish Medical Center
United States (USA) (US)
University of Southampton
United Kingdom (GB)
How to cite
APA:
Kavanaugh, A., Gladman, D.D., Edwards, C.J., Schett, G., Guerette, B., Delev, N.,... Mease, P.J. (2018). 5-YEAR EFFICACY AND SAFETY OF APREMILAST TREATMENT IN SUBJECTS WITH PSORIATIC ARTHRITIS: POOLED ANALYSIS OF THE PALACE STUDIES. (pp. 365-366).
MLA:
Kavanaugh, A., et al. "5-YEAR EFFICACY AND SAFETY OF APREMILAST TREATMENT IN SUBJECTS WITH PSORIATIC ARTHRITIS: POOLED ANALYSIS OF THE PALACE STUDIES." 2018. 365-366.
BibTeX: Download